Breaking News Instant updates and real-time market news.

AAXN

Axon

$62.68

-0.15 (-0.24%)

, T

AT&T

$34.00

-0.12 (-0.35%)

15:59
10/07/18
10/07
15:59
10/07/18
15:59

Axon launches TASER 7, Axon Body 3

Axon (AAXN) announced its seventh generation TASER conducted energy weapon, TASER 7, and its first connected body camera, Axon Body 3 with LTE. The Axon Body 3 will be wirelessly connected via FirstNet, Built with AT&T (T), and Verizon (VZ). Axon also announced that it is offering Axon Records, a revolutionary records management system, free for five years to any agency that purchases the TASER 7 and the Axon Body 3 on the Officer Safety Plan through 2019.

AAXN

Axon

$62.68

-0.15 (-0.24%)

T

AT&T

$34.00

-0.12 (-0.35%)

VZ

Verizon

$54.94

-0.08 (-0.15%)

  • 10

    Oct

  • 12

    Oct

  • 21

    Oct

  • 24

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

AAXN Axon
$62.68

-0.15 (-0.24%)

09/14/18
RAJA
09/14/18
INITIATION
Target $79
RAJA
Outperform
Axon initiated with an Outperform at Raymond James
Raymond James initiated Axon with an Outperform and $79 price target.
08/08/18
IMPC
08/08/18
UPGRADE
Target $62
IMPC
Outperform
Imperial upgrades Axon to Outperform amid post-earnings selloff
Imperial Capital analyst Saliq Khan upgraded Axon Enterprise to Outperform from In-Line and raised his price target for the shares to $62 from $50. The stock in intraday trading is down 11.5%, or $7.77, to $59.85 following the company's Q2 results. Axon's efforts to create an end-to-end public safety platform, from weapons to data and records management, is likely to see continued growth for the next several years, Khan tells investors in a post-earnings research note. He attributes today's selloff to the 100 basis point hit to fiscal 2018 adjusted EBITDA margin as a result of the Vievu acquisition integration, reselling DJI drones at a lower margin, and the increase in operating expenses and investments in the Weapons segment. The analyst the building of a recurring revenue model is key to his long-term optimism on Axon.
10/02/18
BARD
10/02/18
NO CHANGE
Target $69
BARD
Neutral
Baird calls new Taser from Axon a 'significant positive'
Axon Enterprise earlier today announced that it will unveil a new Taser and body camera at the IACP conference this weekend, Baird analyst William Power tells investors in a research note titled "New Taser a Significant Positive." The analyst believes a next generation Taser is likely to reinvigorate growth as the last Taser was announced over five years ago. Further, the analyst is also positive on the body camera release. However, Power keeps a Neutral rating on Axon with a $69 price target. The stock in late morning trading is down 2.5%, or $1.65, to $65.19.
08/08/18
IMPC
08/08/18
UPGRADE
IMPC
Outperform
Axon upgraded to Outperform from In-Line at Imperial Capital
T AT&T
$34.00

-0.12 (-0.35%)

10/05/18
NOMU
10/05/18
DOWNGRADE
Target $31
NOMU
Neutral
Nomura Instinet downgrades CommScope to Neutral with $31 price target
Nomura Instinet analyst Jeffrey Kvaal downgraded CommScope (COMM) to Neutral from Buy and lowered his price target for the shares to $31 from $35. The analyst continues to view CommScope as a long-term beneficiary of both mobile and fiber spending growth. However, he believes that current tailwinds "appear less muscular than hoped." While CommScope and AT&T (T) initially planned to reach 15,000 towers with its FirstNet build by September 2018, that plan has softened to 15,000 by March 2019, Kvaal tells investors in a research note. He expects Q2 to prove the peak of FirstNet spending until mid-2019.
09/25/18
MKMP
09/25/18
NO CHANGE
Target $7.5
MKMP
Buy
Nokia gaining 5G market share with AT&T, says MKM Partners
MKM Partners analyst Michael Genovese kept his Buy rating and $7.50 price target on Nokia (NOK), saying his checks indicate that the company has "gained significant 5G base station market share at AT&T (T) at Ericsson's (ERIC) expense". The analyst notes that while 4G/LTE market share at AT&T was 65% Ericsson and 35% Nokia, the 5G Wireless Access infrastructure market share is likely at 65% Nokia and 35% Samsung (SSNLF). Genovese sees Nokia becoming the "prime infrastructure vendor" heading into 2019 - the year of "major positive global inflection for 5G".
09/24/18
DBAB
09/24/18
NO CHANGE
DBAB
Buy
Deutsche Bank adds AT&T to Catalyst Call Buy list
Deutsche Bank analyst Matthew Niknam added AT&T to his firm's Catalyst Call Buy list saying he sees an "attractive setup" for the stock ahead of the company's Q3 results. The analyst sees "improving second derivative trends" in AT&T's two biggest segments this quarter, or Wireless and Entertainment Group. He believes the company can post upside to consensus earnings and free cash flow expectations for both Q3 and future periods and keeps a Buy rating on the shares.
09/21/18
09/21/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) upgraded to Neutral from Underweight at JPMorgan with analyst Matthew Boss saying he views the stock's risk/reward as more balanced following the recent underperformance. 2. Acadia (ACAD) upgraded to Overweight from Neutral at Piper Jaffray with analyst Danielle Brill citing the FDA announcement of maintained support for Nuplazid after its review. 3. AT&T (T) upgraded to Buy from Neutral at UBS with analyst John Hodulik saying the stock is trading near all-time low valuations, and at its widest valuation gap to Verizon (VZ), given a mix of EBITDA declines, concerns over the debt load and secular issues impacting the space. 4. Diamond Offshore (DO) upgraded to Buy from Hold at HSBC. 5. Ingersoll-Rand (IR) upgraded to Overweight from Neutral at JPMorgan with analyst Stephen Tusa saying he views the stock's discounted valuation relative to peers as unwarranted following the company's transformation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VZ Verizon
$54.94

-0.08 (-0.15%)

10/01/18
UBSW
10/01/18
NO CHANGE
Target $59
UBSW
Buy
UBS 'constructive' on Verizon given improving wireless trends
UBS analyst John Hodulik reiterated a Buy rating and $59 price target on Verizon Communications after meeting with CEO Hans Vestberg, outgoing CEO Lowell McAdam and CFO Matt Ellis. The primary focus was 5G and 4 pillars of the investment case, Hodulik tells investors in a research note, adding that management expects 5G mobile devices as early as next year, potentially keeping a lid on near-term industry volumes which is generally beneficial for churn and margins. Hodulik says he remains constructive on shares given improving wireless trends.
09/04/18
09/04/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Neutral from Buy at MoffettNathanson with analyst Michael Nathanson saying he believes the shift in engagement and monetization from News Feed to Stories will be a headwind to revenue growth. 2. Verizon (VZ) downgraded to Equal Weight from Overweight at Barclays and to Neutral from Buy at MoffettNathanson. 3. Dollar Tree (DLTR) downgraded to Outperform from Top Pick at RBC Capital with analyst Scot Ciccarelli citing continued struggles at its Family Dollar business of 3 consecutive quarters of disappointing results, weighing on the company's profitability. 4. Seagate (STX) downgraded to Underperform from In Line at Evercore ISI with analyst C.J. Muse citing peaking margins and HDD secular headwinds. 5. Signet Jewelers (SIG) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez saying while the company's Q2 sales were better than expected with overall comps of up 1.7%, the underlying fundamentals do not suggest that business is healthy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/18
UBSW
09/21/18
UPGRADE
Target $38
UBSW
Buy
AT&T upgraded to Buy from Neutral at UBS
UBS analyst John Hodulik upgraded AT&T (T) to Buy and raised his price target for the shares to $38 from $33. The shares closed yesterday up 7c to $33.44. The stock is trading near all-time low valuations, and at its widest valuation gap to Verizon Communicators (VZ), given a mix of EBITDA declines, concerns over the debt load and secular issues impacting the space, Hodulik tells investors in a research note. Further, the Time Warner transaction and accounting changes "have compounded these issues, leading to a loss of visibility for investors," the analyst adds. However, his work indicates that AT&T will return to EBITDA growth in the second half of 2018, after a 6% decline in the first half, due to growth in Wireless and WarnerMedia as well as slower declines in Entertainment.
09/21/18
09/21/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS SAYS BUY AT&T: UBS analyst John Hodulik upgraded AT&T (T) to Buy and raised his price target for the shares to $38 from $33, noting that the stock is trading near all-time low valuations and at its widest valuation gap to Verizon (VZ). The Time Warner transaction and accounting changes "have compounded [other] issues, leading to a loss of visibility for investors," but his work indicates that AT&T will return to EBITDA growth in the second half of 2018, after a 6% decline in the first half, due to growth in Wireless and WarnerMedia as well as slower declines in Entertainment. JPMORGAN GOES TO BULL FROM BEAR ON NOVAVAX: JPMorgan analyst Eric Joseph double upgraded Novavax (NVAX) to Overweight from Underweight saying the risk/reward is favorable into the report of Prepare trial data in Q1 of 2019. The trial is assessing the efficacy of the company's RSV F Vaccine for infants via maternal immunization and the analyst believes the shares can hit a range of $2.00 to $2.25, he told investors. JPMORGAN SUGGESTS BEING SHORT COPART, LONG KAR: JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman told investors. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect." LOOP SETS $8.25 TARGET ON HARMONIC: Loop Capital analyst James Kisner initiated Harmonic (HLIT) with a Buy rating and $8.25 price target, saying he believes Harmonic can "drive robust revenue growth on its Cable Edge business as cable operators like Comcast (CMCSA, CMCSK) adopt its virtual CCAP/CMTS solution," and that the company's video business with stabilize. 'DON'T PANIC' OVER DOD PROPOSAL: Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, mainly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Publicly-traded defense contractors include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).

TODAY'S FREE FLY STORIES

LYB

LyondellBasell

$89.14

0.63 (0.71%)

17:07
02/22/19
02/22
17:07
02/22/19
17:07
Syndicate
Breaking Syndicate news story on LyondellBasell »

LyondellBasell files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCCO

Technical Comm Corp

$2.76

0.17 (6.56%)

17:06
02/22/19
02/22
17:06
02/22/19
17:06
Hot Stocks
Technical Comm Corp to submit plan to regain compliance with Nasdaq by March 4 »

Technical Comm Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFU

InfuSystem

$4.15

0.04 (0.97%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
InfuSystem announces settlement of derivative lawsuit »

InfuSystem Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALU

Kaiser Aluminum

$108.22

-1.9 (-1.73%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
Kaiser Aluminum names Neal West as new CFO »

Kaiser Aluminum announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$14.35

0.19 (1.34%)

17:00
02/22/19
02/22
17:00
02/22/19
17:00
Hot Stocks
Alder Biopharmaceuticals submits eptinezumab BLA to FDA »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

RF

Regions Financial

$16.24

-0.01 (-0.06%)

16:59
02/22/19
02/22
16:59
02/22/19
16:59
Syndicate
Breaking Syndicate news story on Regions Financial »

Regions Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

HL

Hecla Mining

$2.59

-0.145 (-5.31%)

16:58
02/22/19
02/22
16:58
02/22/19
16:58
Syndicate
Breaking Syndicate news story on Hecla Mining »

Hecla Mining files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

, CELG

Celgene

$89.15

0.54 (0.61%)

16:52
02/22/19
02/22
16:52
02/22/19
16:52
Hot Stocks
Bristol-Myers files proxy statement in connection with proposed Celgene merger »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

CELG

Celgene

$89.15

0.54 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 28

    Feb

  • 18

    May

  • 20

    May

  • 28

    May

TEN

Tenneco

$36.29

0.76 (2.14%)

16:48
02/22/19
02/22
16:48
02/22/19
16:48
Earnings
Tenneco sees FY19 revenue growth up 4%-5%, consensus $4.65B »

The company expects 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

TEN

Tenneco

$36.29

0.76 (2.14%)

16:46
02/22/19
02/22
16:46
02/22/19
16:46
Earnings
Tenneco reports preliminary Q4 revenue $4.3B, consensus $4.3B »

Sees FY18 EPS "near…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

XRX

Xerox

$31.50

0.16 (0.51%)

16:44
02/22/19
02/22
16:44
02/22/19
16:44
Conference/Events
Xerox management to meet with Loop Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TWTR

Twitter

$31.70

0.94 (3.06%)

16:38
02/22/19
02/22
16:38
02/22/19
16:38
Hot Stocks
Twitter board member Evan Williams to step down at end of month »

On February 22, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

ALLY

Ally Financial

$26.95

-0.07 (-0.26%)

16:34
02/22/19
02/22
16:34
02/22/19
16:34
Hot Stocks
Ally Financial CEO sells over 97,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Mar

  • 28

    May

DAL

Delta Air Lines

$51.52

0.04 (0.08%)

16:33
02/22/19
02/22
16:33
02/22/19
16:33
Hot Stocks
Delta Air Lines' West sells 36,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REN

Resolute Energy

$31.61

0.09 (0.29%)

16:30
02/22/19
02/22
16:30
02/22/19
16:30
Hot Stocks
Resolute Energy stockholders approve merger with Cimarex Energy »

Resolute Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

16:30
02/22/19
02/22
16:30
02/22/19
16:30
Options
Preliminary option volume of 18.8M today »

Preliminary option volume…

ORI

Old Republic

$21.14

0.04 (0.19%)

16:22
02/22/19
02/22
16:22
02/22/19
16:22
Hot Stocks
Old Republic raises quarterly dividend to 20c from 19.5c per share »

This dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
02/22/19
02/22
16:20
02/22/19
16:20
Options
Closing CBOE SPX and VIX Index summary for February 22nd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
02/22/19
02/22
16:17
02/22/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFC

Ellington Financial

$16.97

-0.01 (-0.06%)

16:16
02/22/19
02/22
16:16
02/22/19
16:16
Hot Stocks
Ellington Financial to convert to a Delaware corporation »

Ellington Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
02/22/19
02/22
16:16
02/22/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$11.38

0.08 (0.71%)

16:14
02/22/19
02/22
16:14
02/22/19
16:14
Syndicate
Breaking Syndicate news story on EnLink Midstream »

EnLink Midstream files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 07

    Aug

  • 06

    Nov

KHC

Kraft Heinz

$34.97

-13.225 (-27.44%)

, K

Kellogg

$56.72

-1.61 (-2.76%)

16:13
02/22/19
02/22
16:13
02/22/19
16:13
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks opened in positive…

KHC

Kraft Heinz

$34.97

-13.225 (-27.44%)

K

Kellogg

$56.72

-1.61 (-2.76%)

STMP

Stamps.com

$83.32

-114.76 (-57.94%)

INTC

Intel

$52.43

1.03 (2.00%)

ZG

Zillow

$43.65

8.58 (24.47%)

Z

Zillow

$44.23

9.2 (26.26%)

W

Wayfair

$150.01

32.87 (28.06%)

ROKU

Roku

$64.85

13.38 (26.00%)

DPLO

Diplomat Pharmacy

$5.87

-7.59 (-56.39%)

CASA

Casa Systems

$10.29

-1.67 (-13.96%)

DBX

Dropbox

$23.49

-2.09 (-8.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 03

    Mar

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

SVA

Sinovac Biotech

$6.55

0.08 (1.24%)

16:11
02/22/19
02/22
16:11
02/22/19
16:11
Hot Stocks
Sinovac Biotech trading halted by the Nasdaq »

The Nasdaq Stock Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHIL

Diamond Hill Investment Group Inc

$145.50

-7.6 (-4.96%)

16:10
02/22/19
02/22
16:10
02/22/19
16:10
Hot Stocks
Diamond Hill Investment chairman Ric Dillon to retire »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.